Response to: ‘MBDA: what is it good for?’ by Yazici et al
Response to: ‘MBDA: what is it good for?’ by Yazici et al
About this item
Full title
Author / Creator
Publisher
England: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
By analysing archived baseline samples from the SWEFOT study, we found that MBDA predicted radiographic progression at 1 year in early patients with RA and that MBDA was a stronger predictor of radiographic progression than conventional measures of disease activity at baseline, such as Disease Activity Score in 28 Joints, C-reactive protein or eryt...
Alternative Titles
Full title
Response to: ‘MBDA: what is it good for?’ by Yazici et al
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_swepub_ki_se_519285
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_519285
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2014-206383
